Company intelligence / Profile preview
Kind Pharmaceuticals LLC
San Francisco, California, United Statesen.kindpharmaceutical.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
Lead candidate AND017 received FDA Orphan Drug Designation for Sickle Cell Disease and FDA approval for investigational new drug application for clinical trials. Phase 1 and Phase 2 clinical trials for anemia in NDD-CKD and DD-CKD have been completed with results presented at ASN Kidney Week.
- Therapeutic areas
- HematologyOncologyNephrology
- Modalities
- Small moleculesBiomacromoleculesAntibody-drug conjugates (ADCs)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on Kind Pharmaceuticals LLC.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kind Pharmaceuticals LLC.